Daré Bioscience Ownership 2024 | Who Owns Daré Bioscience Now?
Institutional Ownership
6.44%
Insider Ownership
1.62%
Retail Ownership
91.94%
Institutional Holders
17.00
Daré Bioscience Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 3.34% | - | 3,358,215 | -92,113 | -2.67% | 1,128,696 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.00% | - | 1,006,561 | 17,253 | 1.74% | 371,005 | Jun 30, 2024 |
| AMH EQUITY LTD | 0.92% | 0.41% | 923,619 | 923,619 | 100.00% | 310,428 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.77% | 0.00% | 778,700 | 15,800 | 2.07% | 261,721 | Jun 30, 2024 |
| STATE STREET CORP | 0.28% | - | 282,210 | 34,500 | 13.93% | 94,851,000 | Jun 30, 2024 |
| BLACKROCK INC. | 0.20% | - | 203,632 | -192,466 | -48.59% | 68,441 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.18% | - | 185,485 | 2,183 | 1.19% | 62,342,000 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.10% | 0.00% | 102,896 | 69,604 | 209.07% | 34,583 | Jun 30, 2024 |
| UBS GROUP AG | 0.10% | - | 99,016 | 98,516 | 19703.20% | 33,269 | Jun 30, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.05% | - | 45,925 | - | - | 15,000 | Jun 30, 2024 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 0.03% | - | 30,875 | - | - | 10,377 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.03% | - | 30,532 | - | - | 10,262 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.03% | - | 25,947 | 3,000 | 13.07% | 8,720 | Jun 30, 2024 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 0.02% | - | 20,000 | - | - | 6,722 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.02% | - | 20,000 | - | - | 6,722 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.02% | 0.00% | 15,302 | -5,002 | -24.64% | 5,141 | Jun 30, 2024 |
| CERITY PARTNERS LLC | 0.01% | - | 10,000 | 10,000 | 100.00% | 3,361 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.00% | - | 3,000 | -1,400 | -31.82% | 1,008 | Jun 30, 2024 |
| MATHER GROUP, LLC. | 0.00% | - | 1,000 | 1,000 | 100.00% | 490 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 981 | 835 | 571.92% | 330 | Jun 30, 2024 |
Daré Bioscience's largest institutional shareholder is VANGUARD GROUP INC, holding 3.34% of the company's total share outstanding, currently valued at $1.13M. The top 10 institutional shareholders own together 6.95% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AMH EQUITY LTD | 0.92% | 0.41% | 923,619 | 923,619 | 100.00% | 310,428 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.77% | 0.00% | 778,700 | 15,800 | 2.07% | 261,721 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.10% | 0.00% | 102,896 | 69,604 | 209.07% | 34,583 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.02% | 0.00% | 15,302 | -5,002 | -24.64% | 5,141 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.00% | - | 1,006,561 | 17,253 | 1.74% | 371,005 | Jun 30, 2024 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 0.03% | - | 30,875 | - | - | 10,377 | Jun 30, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.05% | - | 45,925 | - | - | 15,000 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.34% | - | 3,358,215 | -92,113 | -2.67% | 1,128,696 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.02% | - | 20,000 | - | - | 6,722 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.18% | - | 185,485 | 2,183 | 1.19% | 62,342,000 | Jun 30, 2024 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 0.02% | - | 20,000 | - | - | 6,722 | Jun 30, 2024 |
| CERITY PARTNERS LLC | 0.01% | - | 10,000 | 10,000 | 100.00% | 3,361 | Jun 30, 2024 |
| UBS GROUP AG | 0.10% | - | 99,016 | 98,516 | 19703.20% | 33,269 | Jun 30, 2024 |
| MATHER GROUP, LLC. | 0.00% | - | 1,000 | 1,000 | 100.00% | 490 | Jun 30, 2024 |
| STATE STREET CORP | 0.28% | - | 282,210 | 34,500 | 13.93% | 94,851,000 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.03% | - | 30,532 | - | - | 10,262 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.03% | - | 25,947 | 3,000 | 13.07% | 8,720 | Jun 30, 2024 |
| BLACKROCK INC. | 0.20% | - | 203,632 | -192,466 | -48.59% | 68,441 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.00% | - | 3,000 | -1,400 | -31.82% | 1,008 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 981 | 835 | 571.92% | 330 | Jun 30, 2024 |
The largest Daré Bioscience shareholder by % of total assets is AMH EQUITY LTD. The company owns 923.62K shares of Daré Bioscience (DARE), representing 0.41% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AMH EQUITY LTD | 0.92% | 0.41% | 923,619 | 923,619 | 100.00% | 310,428 | Jun 30, 2024 |
| UBS GROUP AG | 0.10% | - | 99,016 | 98,516 | 19703.20% | 33,269 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.10% | 0.00% | 102,896 | 69,604 | 209.07% | 34,583 | Jun 30, 2024 |
| STATE STREET CORP | 0.28% | - | 282,210 | 34,500 | 13.93% | 94,851,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.00% | - | 1,006,561 | 17,253 | 1.74% | 371,005 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.77% | 0.00% | 778,700 | 15,800 | 2.07% | 261,721 | Jun 30, 2024 |
| CERITY PARTNERS LLC | 0.01% | - | 10,000 | 10,000 | 100.00% | 3,361 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.03% | - | 25,947 | 3,000 | 13.07% | 8,720 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.18% | - | 185,485 | 2,183 | 1.19% | 62,342,000 | Jun 30, 2024 |
| MATHER GROUP, LLC. | 0.00% | - | 1,000 | 1,000 | 100.00% | 490 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 981 | 835 | 571.92% | 330 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 249 | 10 | 4.18% | 84 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.03% | - | 30,532 | - | - | 10,262 | Jun 30, 2024 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 0.02% | - | 20,000 | - | - | 6,722 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.02% | - | 20,000 | - | - | 6,722 | Jun 30, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.05% | - | 45,925 | - | - | 15,000 | Jun 30, 2024 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 0.03% | - | 30,875 | - | - | 10,377 | Jun 30, 2024 |
| NEWEDGE ADVISORS, LLC | - | - | - | -10 | -100.00% | - | Jun 30, 2024 |
| CORNERSTONE PLANNING GROUP LLC | - | - | - | -16 | -100.00% | - | Jun 30, 2024 |
| CALDWELL SUTTER CAPITAL, INC. | - | - | - | -200 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Daré Bioscience's largest institutional buyer is AMH EQUITY LTD. The company purchased 923.62K stocks of DARE, valued at $310.43K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 0.20% | - | 203,632 | -192,466 | -48.59% | 68,441 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -125,900 | -100.00% | - | Jun 30, 2024 |
| FOUNDERS FINANCIAL SECURITIES LLC | - | - | - | -124,000 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.34% | - | 3,358,215 | -92,113 | -2.67% | 1,128,696 | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -28,093 | -100.00% | - | Jun 30, 2024 |
| OBJECTIVITY SQUARED, LLC | - | - | - | -27,000 | -100.00% | - | Jun 30, 2024 |
| ADVISORY SERVICES NETWORK, LLC | - | - | - | -15,000 | -100.00% | - | Jun 30, 2024 |
| FIRST AFFIRMATIVE FINANCIAL NETWORK | - | - | - | -12,211 | -100.00% | - | Jun 30, 2024 |
| IFS ADVISORS, LLC | - | - | - | -11,400 | -100.00% | - | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | - | - | - | -10,800 | -100.00% | - | Jun 30, 2024 |
| FIRST PACIFIC FINANCIAL | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.02% | 0.00% | 15,302 | -5,002 | -24.64% | 5,141 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.00% | - | 3,000 | -1,400 | -31.82% | 1,008 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -771 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | 0.00% | - | 503 | -573 | -53.25% | 169 | Jun 30, 2024 |
| CALDWELL SUTTER CAPITAL, INC. | - | - | - | -200 | -100.00% | - | Jun 30, 2024 |
| CORNERSTONE PLANNING GROUP LLC | - | - | - | -16 | -100.00% | - | Jun 30, 2024 |
| NEWEDGE ADVISORS, LLC | - | - | - | -10 | -100.00% | - | Jun 30, 2024 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 0.03% | - | 30,875 | - | - | 10,377 | Jun 30, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.05% | - | 45,925 | - | - | 15,000 | Jun 30, 2024 |
As of Jun 30 2024, Daré Bioscience's biggest institutional seller is BLACKROCK INC.. The company sold -0.19M shares of DARE, valued at $68.44K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AMH EQUITY LTD | 0.92% | 0.41% | 923,619 | 923,619 | 100.00% | 310,428 | Jun 30, 2024 |
| CERITY PARTNERS LLC | 0.01% | - | 10,000 | 10,000 | 100.00% | 3,361 | Jun 30, 2024 |
| MATHER GROUP, LLC. | 0.00% | - | 1,000 | 1,000 | 100.00% | 490 | Jun 30, 2024 |
Daré Bioscience's largest new institutional shareholder by number of shares is AMH EQUITY LTD, purchased 923.62K shares, valued at $310.43K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -125,900 | -100.00% | - | Jun 30, 2024 |
| FOUNDERS FINANCIAL SECURITIES LLC | - | - | - | -124,000 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -28,093 | -100.00% | - | Jun 30, 2024 |
| OBJECTIVITY SQUARED, LLC | - | - | - | -27,000 | -100.00% | - | Jun 30, 2024 |
| ADVISORY SERVICES NETWORK, LLC | - | - | - | -15,000 | -100.00% | - | Jun 30, 2024 |
| FIRST AFFIRMATIVE FINANCIAL NETWORK | - | - | - | -12,211 | -100.00% | - | Jun 30, 2024 |
| IFS ADVISORS, LLC | - | - | - | -11,400 | -100.00% | - | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | - | - | - | -10,800 | -100.00% | - | Jun 30, 2024 |
| FIRST PACIFIC FINANCIAL | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -771 | -100.00% | - | Jun 30, 2024 |
| CALDWELL SUTTER CAPITAL, INC. | - | - | - | -200 | -100.00% | - | Jun 30, 2024 |
| CORNERSTONE PLANNING GROUP LLC | - | - | - | -16 | -100.00% | - | Jun 30, 2024 |
| NEWEDGE ADVISORS, LLC | - | - | - | -10 | -100.00% | - | Jun 30, 2024 |
Daré Bioscience's largest sold out institutional shareholder by shares sold is PRICE T ROWE ASSOCIATES INC /MD/, sold -0.13M shares, valued at -, as of undefined.
Daré Bioscience Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| VANGUARD VALLEY FORGE FUNDS | 0.09% | 47,270 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 3,322,935 | -944,370 | -22.13% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 909,587 | 149,136 | 19.61% | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 44,843 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 30,532 | - | - | Jan 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 23,256 | - | - | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 9,509 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 14,808 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 177,658 | -6,547 | -3.55% | Mar 31, 2024 |
Daré Bioscience's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 47.27K shares, compromising 0.09% of its total assets.
Daré Bioscience Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 17 | -51.43% |
| 31 Mar, 24 | 35 | 6.06% |
| 31 Dec, 23 | 33 | 13.79% |
| 30 Sep, 23 | 29 | 11.54% |
| 30 Jun, 23 | 26 | -7.14% |
| 31 Mar, 23 | 28 | -3.45% |
| 31 Dec, 22 | 29 | - |
| 30 Sep, 22 | 29 | -17.14% |
| 30 Jun, 22 | 35 | -7.89% |
| 31 Mar, 22 | 38 | 2.70% |
| 31 Dec, 21 | 37 | 8.82% |
| 30 Sep, 21 | 34 | 13.33% |
| 30 Jun, 21 | 30 | 15.38% |
| 31 Mar, 21 | 26 | 8.33% |
| 31 Dec, 20 | 24 | 33.33% |
| 30 Sep, 20 | 18 | 12.50% |
| 30 Jun, 20 | 16 | -5.88% |
| 31 Mar, 20 | 17 | 21.43% |
| 31 Dec, 19 | 14 | -6.67% |
| 30 Sep, 19 | 15 | 25.00% |
| 30 Jun, 19 | 12 | -7.69% |
| 31 Mar, 19 | 13 | - |
| 31 Dec, 18 | 13 | -13.33% |
| 30 Sep, 18 | 15 | 15.38% |
| 30 Jun, 18 | 13 | 30.00% |
| 31 Mar, 18 | 10 | - |
| 31 Dec, 17 | 10 | - |
| 30 Sep, 17 | 10 | - |
As of 30 Jun 24, 17 institutions are holding Daré Bioscience's shares, representing a decrease of -51.43% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 6,474,060 | -5.14% |
| 31 Mar, 24 | 6,824,644 | 3.85% |
| 31 Dec, 23 | 6,571,807 | -48.97% |
| 30 Sep, 23 | 12,879,096 | 99.44% |
| 30 Jun, 23 | 6,457,579 | -5.53% |
| 31 Mar, 23 | 6,835,825 | -1.92% |
| 31 Dec, 22 | 6,969,612 | -10.09% |
| 30 Sep, 22 | 7,751,634 | 5.12% |
| 30 Jun, 22 | 7,373,921 | 11.48% |
| 31 Mar, 22 | 6,614,845 | -3.31% |
| 31 Dec, 21 | 6,841,519 | 42.30% |
| 30 Sep, 21 | 4,807,746 | 43.14% |
| 30 Jun, 21 | 3,358,846 | -6.38% |
| 31 Mar, 21 | 3,587,698 | -27.91% |
| 31 Dec, 20 | 4,976,527 | 124.38% |
| 30 Sep, 20 | 2,217,933 | 36.40% |
| 30 Jun, 20 | 1,626,058 | 74.41% |
| 31 Mar, 20 | 932,336 | 6.09% |
| 31 Dec, 19 | 878,820 | 9.14% |
| 30 Sep, 19 | 805,214 | -5.64% |
| 30 Jun, 19 | 853,358 | 8.22% |
| 31 Mar, 19 | 788,519 | 7.57% |
| 31 Dec, 18 | 733,051 | -15.13% |
| 30 Sep, 18 | 863,779 | 12.31% |
| 30 Jun, 18 | 769,100 | 37.14% |
| 31 Mar, 18 | 560,795 | 15.99% |
| 31 Dec, 17 | 483,480 | -1.53% |
| 30 Sep, 17 | 490,991 | - |
Daré Bioscience (DARE) has 6.47M shares outstanding as of 30 Jun 24, down -5.14% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 6.44% | 13.82% |
| 31 Mar, 24 | 6.83% | 13.10% |
| 31 Dec, 23 | 7.22% | 3.25% |
| 30 Sep, 23 | 14.91% | 26.14% |
| 30 Jun, 23 | 7.55% | 11.82% |
| 31 Mar, 23 | 7.99% | 11.77% |
| 31 Dec, 22 | 8.24% | 9.87% |
| 30 Sep, 22 | 9.14% | 12.05% |
| 30 Jun, 22 | 8.71% | 14.02% |
| 31 Mar, 22 | 7.88% | 8.43% |
| 31 Dec, 21 | 9.67% | 20.95% |
| 30 Sep, 21 | 6.79% | 15.32% |
| 30 Jun, 21 | 6.66% | 10.25% |
| 31 Mar, 21 | 8.06% | 2.95% |
| 31 Dec, 20 | 16.54% | 33.55% |
| 30 Sep, 20 | 7.02% | 18.95% |
| 30 Jun, 20 | 6.09% | 39.67% |
| 31 Mar, 20 | 3.92% | 28.73% |
| 31 Dec, 19 | 3.69% | 15.85% |
| 30 Sep, 19 | 4.83% | 17.19% |
| 30 Jun, 19 | 5.30% | 11.12% |
| 31 Mar, 19 | 6.90% | 16.76% |
| 31 Dec, 18 | 6.42% | 11.22% |
| 30 Sep, 18 | 7.56% | 16.68% |
| 30 Jun, 18 | 6.73% | 16.15% |
| 31 Mar, 18 | 6.46% | 20.83% |
| 31 Dec, 17 | 5.57% | 5.74% |
| 30 Sep, 17 | 9.85% | - |
As of 30 Jun 24, Daré Bioscience is held by 6.44% institutional shareholders, representing a 13.82% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 7 | -50.00% |
| 31 Mar, 24 | 14 | -30.00% |
| 31 Dec, 23 | 20 | 81.82% |
| 30 Sep, 23 | 11 | 83.33% |
| 30 Jun, 23 | 6 | -33.33% |
| 31 Mar, 23 | 9 | 28.57% |
| 31 Dec, 22 | 7 | -56.25% |
| 30 Sep, 22 | 16 | -23.81% |
| 30 Jun, 22 | 21 | -12.50% |
| 31 Mar, 22 | 24 | 9.09% |
| 31 Dec, 21 | 22 | - |
| 30 Sep, 21 | 22 | 29.41% |
| 30 Jun, 21 | 17 | 41.67% |
| 31 Mar, 21 | 12 | -20.00% |
| 31 Dec, 20 | 15 | 150.00% |
| 30 Sep, 20 | 6 | -14.29% |
| 30 Jun, 20 | 7 | -30.00% |
| 31 Mar, 20 | 10 | 100.00% |
| 31 Dec, 19 | 5 | 25.00% |
| 30 Sep, 19 | 4 | -50.00% |
| 30 Jun, 19 | 8 | - |
| 31 Mar, 19 | 8 | 33.33% |
| 31 Dec, 18 | 6 | - |
| 30 Sep, 18 | 6 | -14.29% |
| 30 Jun, 18 | 7 | - |
| 31 Mar, 18 | 7 | 75.00% |
| 31 Dec, 17 | 4 | -60.00% |
| 30 Sep, 17 | 10 | - |
7 institutional shareholders have increased their position in DARE stock as of 30 Jun 24 compared to 14 in the previous quarter (a -50.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 5 | -37.50% |
| 31 Mar, 24 | 8 | 166.67% |
| 31 Dec, 23 | 3 | - |
| 30 Sep, 23 | 3 | -50.00% |
| 30 Jun, 23 | 6 | -40.00% |
| 31 Mar, 23 | 10 | -9.09% |
| 31 Dec, 22 | 11 | 175.00% |
| 30 Sep, 22 | 4 | -20.00% |
| 30 Jun, 22 | 5 | 66.67% |
| 31 Mar, 22 | 3 | -40.00% |
| 31 Dec, 21 | 5 | 66.67% |
| 30 Sep, 21 | 3 | -40.00% |
| 30 Jun, 21 | 5 | -37.50% |
| 31 Mar, 21 | 8 | 700.00% |
| 31 Dec, 20 | 1 | -80.00% |
| 30 Sep, 20 | 5 | - |
| 30 Jun, 20 | - | -100.00% |
| 31 Mar, 20 | 2 | 100.00% |
| 31 Dec, 19 | 1 | -50.00% |
| 30 Sep, 19 | 2 | - |
| 30 Jun, 19 | - | -100.00% |
| 31 Mar, 19 | 1 | -66.67% |
| 31 Dec, 18 | 3 | - |
| 30 Sep, 18 | 3 | 50.00% |
| 30 Jun, 18 | 2 | - |
| 31 Mar, 18 | - | -100.00% |
| 31 Dec, 17 | 3 | - |
| 30 Sep, 17 | - | - |
5 institutional shareholders have reduced their position in DARE stock as of 30 Jun 24 compared to 8 in the previous quarter (a -37.50% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 17 | -51.43% | 6,474,060 | -5.14% | 6.44% | 13.82% | 7 | -50.00% | 5 | -37.50% |
| 31 Mar, 24 | 35 | 6.06% | 6,824,644 | 3.85% | 6.83% | 13.10% | 14 | -30.00% | 8 | 166.67% |
| 31 Dec, 23 | 33 | 13.79% | 6,571,807 | -48.97% | 7.22% | 3.25% | 20 | 81.82% | 3 | - |
| 30 Sep, 23 | 29 | 11.54% | 12,879,096 | 99.44% | 14.91% | 26.14% | 11 | 83.33% | 3 | -50.00% |
| 30 Jun, 23 | 26 | -7.14% | 6,457,579 | -5.53% | 7.55% | 11.82% | 6 | -33.33% | 6 | -40.00% |
| 31 Mar, 23 | 28 | -3.45% | 6,835,825 | -1.92% | 7.99% | 11.77% | 9 | 28.57% | 10 | -9.09% |
| 31 Dec, 22 | 29 | - | 6,969,612 | -10.09% | 8.24% | 9.87% | 7 | -56.25% | 11 | 175.00% |
| 30 Sep, 22 | 29 | -17.14% | 7,751,634 | 5.12% | 9.14% | 12.05% | 16 | -23.81% | 4 | -20.00% |
| 30 Jun, 22 | 35 | -7.89% | 7,373,921 | 11.48% | 8.71% | 14.02% | 21 | -12.50% | 5 | 66.67% |
| 31 Mar, 22 | 38 | 2.70% | 6,614,845 | -3.31% | 7.88% | 8.43% | 24 | 9.09% | 3 | -40.00% |
| 31 Dec, 21 | 37 | 8.82% | 6,841,519 | 42.30% | 9.67% | 20.95% | 22 | - | 5 | 66.67% |
| 30 Sep, 21 | 34 | 13.33% | 4,807,746 | 43.14% | 6.79% | 15.32% | 22 | 29.41% | 3 | -40.00% |
| 30 Jun, 21 | 30 | 15.38% | 3,358,846 | -6.38% | 6.66% | 10.25% | 17 | 41.67% | 5 | -37.50% |
| 31 Mar, 21 | 26 | 8.33% | 3,587,698 | -27.91% | 8.06% | 2.95% | 12 | -20.00% | 8 | 700.00% |
| 31 Dec, 20 | 24 | 33.33% | 4,976,527 | 124.38% | 16.54% | 33.55% | 15 | 150.00% | 1 | -80.00% |
| 30 Sep, 20 | 18 | 12.50% | 2,217,933 | 36.40% | 7.02% | 18.95% | 6 | -14.29% | 5 | - |
| 30 Jun, 20 | 16 | -5.88% | 1,626,058 | 74.41% | 6.09% | 39.67% | 7 | -30.00% | - | -100.00% |
| 31 Mar, 20 | 17 | 21.43% | 932,336 | 6.09% | 3.92% | 28.73% | 10 | 100.00% | 2 | 100.00% |
| 31 Dec, 19 | 14 | -6.67% | 878,820 | 9.14% | 3.69% | 15.85% | 5 | 25.00% | 1 | -50.00% |
| 30 Sep, 19 | 15 | 25.00% | 805,214 | -5.64% | 4.83% | 17.19% | 4 | -50.00% | 2 | - |
| 30 Jun, 19 | 12 | -7.69% | 853,358 | 8.22% | 5.30% | 11.12% | 8 | - | - | -100.00% |
| 31 Mar, 19 | 13 | - | 788,519 | 7.57% | 6.90% | 16.76% | 8 | 33.33% | 1 | -66.67% |
| 31 Dec, 18 | 13 | -13.33% | 733,051 | -15.13% | 6.42% | 11.22% | 6 | - | 3 | - |
| 30 Sep, 18 | 15 | 15.38% | 863,779 | 12.31% | 7.56% | 16.68% | 6 | -14.29% | 3 | 50.00% |
| 30 Jun, 18 | 13 | 30.00% | 769,100 | 37.14% | 6.73% | 16.15% | 7 | - | 2 | - |
| 31 Mar, 18 | 10 | - | 560,795 | 15.99% | 6.46% | 20.83% | 7 | 75.00% | - | -100.00% |
| 31 Dec, 17 | 10 | - | 483,480 | -1.53% | 5.57% | 5.74% | 4 | -60.00% | 3 | - |
| 30 Sep, 17 | 10 | - | 490,991 | - | 9.85% | - | 10 | - | - | - |
Daré Bioscience Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Daré Bioscience's stock was made by Haring-Layton MarDee on Jan 29 2024, selling 3,500 shares at $2.37 per share (valued at $8.29K).
Daré Bioscience Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 5 | - | - |
| Q1 2024 | 3 | 7 | 42.86% |
| Q2 2023 | 7 | - | - |
| Q1 2023 | 3 | - | - |
| Q2 2022 | 12 | - | - |
| Q1 2022 | 3 | - | - |
| Q2 2021 | 7 | - | - |
| Q1 2021 | 3 | - | - |
| Q2 2020 | 6 | - | - |
| Q1 2020 | 3 | 2 | 150.00% |
| Q4 2019 | 1 | - | - |
| Q2 2019 | 7 | - | - |
| Q1 2019 | 2 | - | - |
| Q3 2018 | 8 | - | - |
| Q2 2018 | 1 | - | - |
| Q3 2017 | 12 | - | - |
| Q2 2017 | 1 | - | - |
| Q1 2017 | 16 | - | - |
| Q4 2016 | 8 | 12 | 66.67% |
| Q3 2016 | 4 | - | - |
5 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Daré Bioscience's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | - | - |
| Q2 2019 | 1 | - | - |
| Q1 2019 | - | - | - |
| Q3 2018 | - | - | - |
| Q2 2018 | 1 | - | - |
| Q3 2017 | - | - | - |
| Q2 2017 | - | - | - |
| Q1 2017 | - | - | - |
| Q4 2016 | - | - | - |
| Q3 2016 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Daré Bioscience's stocks.
Daré Bioscience Peer Ownership
| Ticker | Company |
|---|---|
| NUVB | Nuvation Bio Inc. |
| NXTC | NextCure, Inc. |
| PULM | Pulmatrix, Inc. |
| EYPT | EyePoint Pharmaceuticals, Inc. |
| XBIO | Xenetic Biosciences, Inc. |
| RVPH | Reviva Pharmaceuticals Holdings, Inc. |
| BPTH | Bio-Path Holdings, Inc. |
| ALEC | Alector, Inc. |
| SNSE | Sensei Biotherapeutics, Inc. |
| OCUP | Ocuphire Pharma, Inc. |
| BDTX | Black Diamond Therapeutics, Inc. |
| GRPH | LENZ Therapeutics, Inc. |
| PASG | Passage Bio, Inc. |
| SLS | SELLAS Life Sciences Group, Inc. |
| CYTO | Altamira Therapeutics Ltd. |
| MBRX | Moleculin Biotech, Inc. |
| ONTX | Traws Pharma, Inc. |
| KZR | Kezar Life Sciences, Inc. |
| CBIO | Gyre Therapeutics, Inc. |
| MACK | Merrimack Pharmaceuticals, Inc. |
DARE Ownership FAQ
Who Owns Daré Bioscience?
Daré Bioscience is owned by institutional shareholders (6.44%), insiders (1.62%), and public (91.94%). The largest institutional shareholder of Daré Bioscience is VANGUARD GROUP INC (3.34% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.09% of total shares).
Who are the major institutional shareholders of Daré Bioscience?
Daré Bioscience's major institutional shareholders are VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, AMH EQUITY LTD, RENAISSANCE TECHNOLOGIES LLC, and STATE STREET CORP. The top five shareholders own together 6.32% of the company's share outstanding.
How many Daré Bioscience shareholders are there?
As of Jun 2024, there are 17 institutional shareholders of Daré Bioscience.
What percentage of Daré Bioscience is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC owns 3.36M shares of Daré Bioscience, representing 3.34% of the company's total shares outstanding, valued at $1.13M (as of Jun 2024).
What percentage of Daré Bioscience is owned by GEODE CAPITAL MANAGEMENT, LLC?
As of Jun 2024, GEODE CAPITAL MANAGEMENT, LLC holds 1.01M shares of Daré Bioscience (DARE), compromising 1.00% of the company, valued at $371K.
What percentage of Daré Bioscience is owned by AMH EQUITY LTD?
AMH EQUITY LTD is the third largest holder of Daré Bioscience. The company owns 923.62K of the company's shares outstanding (worth $310.43K).